Here, using three different mouse models, we investigated the contribution of TRPV4 channels to the development of sepsis, and sought to determine whether pharmacological blockade of these channels with potent, selective TRPV4 antagonists exerts a protective effect. This evidence concerns the gene TRPV4 and Sepsis.